These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37515156)

  • 21. Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?
    Barbosa M; Marques-Sá J; Carvalho C; Fernandes V
    Arch Endocrinol Metab; 2023 Jun; 67(6):e000649. PubMed ID: 37364151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Serum Glucose Levels on Outcomes in Acute Pancreatitis: A Retrospective Analysis.
    Balaban M; Balaban DV; Enache I; Nedelcu IC; Jinga M; Gheorghe C
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929473
    [No Abstract]   [Full Text] [Related]  

  • 23. Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.
    Cromer SJ; Colling C; Schatoff D; Leary M; Stamou MI; Selen DJ; Putman MS; Wexler DJ
    J Diabetes Complications; 2022 Apr; 36(4):108145. PubMed ID: 35148936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-COVID syndrome, inflammation, and diabetes.
    Rizvi AA; Kathuria A; Al Mahmeed W; Al-Rasadi K; Al-Alawi K; Banach M; Banerjee Y; Ceriello A; Cesur M; Cosentino F; Galia M; Goh SY; Janez A; Kalra S; Kempler P; Lessan N; Lotufo P; Papanas N; Santos RD; Stoian AP; Toth PP; Viswanathan V; Rizzo M;
    J Diabetes Complications; 2022 Nov; 36(11):108336. PubMed ID: 36228563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Diabetes Mellitus and Hyperglycemia on the Severity and Outcome of Patients with COVID-19 Disease: A Single-Center Experience.
    Al Argan R; Alkhafaji D; Al Elq A; Albaker W; Alqatari S; Alzaki A; Alwaheed A; Al Said A; Bukhari H; Al Warthan S; Zeeshan M; AlRubaish F; AlElq Z; Alsahlawi A; Alalwan M; AlHwiesh A; Alabdrabalnabi FI
    Int J Gen Med; 2021; 14():9445-9457. PubMed ID: 34908871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis.
    Klonoff DC; Messler JC; Umpierrez GE; Peng L; Booth R; Crowe J; Garrett V; McFarland R; Pasquel FJ
    Diabetes Care; 2021 Feb; 44(2):578-585. PubMed ID: 33323475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection.
    Burgos R; García-Almeida JM; Matía-Martín P; Palma S; Sanz-Paris A; Zugasti A; Alfaro JJ; Fullana AA; Continente AC; Chicetru MJ; Malpartida KG; Faes ÁG; Sánchez VG; López ML; Ortega AJM; Roldán JO; Moreno CS; Llanos PS
    Rev Endocr Metab Disord; 2022 Apr; 23(2):205-213. PubMed ID: 35244834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.
    Uchihara M; Bouchi R; Kodani N; Saito S; Miyazato Y; Umamoto K; Sugimoto H; Kobayashi M; Hikida S; Akiyama Y; Ihana-Sugiyama N; Ohsugi M; Tanabe A; Ueki K; Takasaki J; Hojo M; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1086-1093. PubMed ID: 35075818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Poor Glycemic Control and Increased Glucose Variability Among Admitted Moderate to Critical COVID-19 Patients with Type 2 Diabetes Mellitus: A Single Center Cross-sectional Study.
    Martin Bagos JP; Erick M; Matawaran B
    J ASEAN Fed Endocr Soc; 2023; 38(2):57-64. PubMed ID: 38045658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 in Patients with Diabetes: Clinical Course, Metabolic Status, Inflammation, and Coagulation Disorder.
    Belikina DV; Malysheva ES; Petrov AV; Nekrasova TA; Nekaeva ES; Lavrova AE; Zarubina DG; Atduev KA; Magomedova DM; Strongin LG
    Sovrem Tekhnologii Med; 2021; 12(5):6-16. PubMed ID: 34796000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.
    Alguwaihes AM; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alzahrani SH; Sabico S; Al-Daghri NM; Jammah AA
    Cardiovasc Diabetol; 2020 Dec; 19(1):205. PubMed ID: 33278893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19.
    Smith SM; Boppana A; Traupman JA; Unson E; Maddock DA; Chao K; Dobesh DP; Brufsky A; Connor RI
    J Med Virol; 2021 Jan; 93(1):409-415. PubMed ID: 32589756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of diabetes mellitus in the clinical course and outcome of SARS-CoV-2 infected patients.
    Maltezou HC; Pavli A; Tsonou P; Balaska A; Raftopoulos V; Papadima K; Andreopoulou A; Tentolouris A; Gamaletsou MN; Sipsas NV; Tentolouris N
    Hormones (Athens); 2022 Jun; 21(2):221-227. PubMed ID: 35138606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia.
    Nair AM; Gopalan S; Rajendran V; Varadaraj P; Marappa L; Pandurangan V; Madhavan S; Mani R; Bhaskar E
    Monaldi Arch Chest Dis; 2022 Apr; 92(4):. PubMed ID: 35416000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19.
    Barmanray RD; Cheuk N; Fourlanos S; Greenberg PB; Colman PG; Worth LJ
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35790320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
    Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.